P. Victor Schut, Chief Executive Officer at AGILeBiotics, is an entrepreneur and experienced CEO/Chief Business Officer with a demonstrated history of working in the biotechnology industry over the past 17 years.
At AGILeBiotics, he is responsible for managing the business and securing funding for the next development stages, i.e. pre-clinical and Phase I studies for the company’s lead antibiotic candidates. Before joining AGILeBiotics he co-founded ProteoNic and served at the company as its CEO and CBO for 15 years. He is co-founder/CEO of Mycology Solutions active in developing treatment for multidrug-resistant fungal infections and operates as independent consultant coaching several biotech start-ups (strategy, business development and funding). Prior to entering the biotech sector, he was active as banker and as investment manager at private equity fund Antea Participaties. He holds a master degree in corporate law from the University of Leiden.